Kalytera Announces Private Placement To Pay For Auditor And Accounting Fees
Kalytera Therapeutics (TSXV: KLY) appears to be in quite the pickle. The company announced this morning that it has received
Read more
Kalytera Therapeutics
Kalytera Therapeutics Provides Update On Acquisition of Stero Biotechs
Kalytera Therapeutics Inc (TSXV: KLY) has released an update on the acquisition terms regarding the planned purchase Israeli company Stero
Read more
Kalytera Therapeutics Terminates Extraction Facility Letter of Intent
Kalytera Therapeutics (TSXV: KLY) announced this morning that it is walking away from a letter of intent signed earlier this
Read more
Kalytera Therapeutics Cancels Vote On Potential Reverse Split Transaction
Kalytera Therapeutics (TSXV: KLY) announced in an after hours news release on Friday evening that it will be removing the
Read more
BRIEF: Kalytera Therapeutics – Four Critical Points
Kalytera Therapeutics (TSXV: KALY) investors had quite the hay day yesterday. At the close, it finished up $0.095, or 38%
Read more